abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

هذه الصفحة غير متوفرة باللغة العربية وهي معروضة باللغة English

المقال

22 يناير 2015

الكاتب:
Aman Malik, International Business Times

Can Obama And Modi Settle The US-India Feud In The Pharmaceuticals Sector?

India and the United States have a problem in the pharmaceuticals sector. And drug-makers in both countries will be keenly watching whether President Barack Obama and Prime Minister Narendra Modi can do anything about it when the former comes visiting India as a state guest at the Republic Day celebrations in New Delhi...The problem is mainly on two fronts -- on the one hand, Indian drug makers...have been getting flak from the U.S. Food and Drug Administration (USFDA) for intellectual property rights (IPR) violations and for allegedly tampering with data; on the other hand, foreign pharmaceutical companies...have been denied patents by India for their drugs.

 

Part of the following timelines

India: Health activists fear decreased access to medicines for the poor - as govt reviews intellectual property laws

India: Discussions with business leaders at CEO Forum & patent laws among other topics to be discussed during Obama's visit